氨碘肽等离子导入治疗玻璃体积血临床观察

Iontophoresis with amiotide,dexamethasone and vitamin C to treat vitreous hemorrhage

目的观察氨碘肽滴眼液、地塞米松注射液、维生素C注射液治疗玻璃体积血的临床疗效。方法选择2011年8月至2013年1月在我院就诊的玻璃体积血患者8l例（81只眼），按照随机法将病例分为观察组41例，对照组40例。对照组给予复方芦丁、复方血栓通、维生素C片口服，观察组在对照组的基础上加用氨碘肽滴眼液、地塞米松注射液、维生素C注射液离子导入的方法。观察两组疗效。结果观察组治疗2-3个疗程后总有效率为90．2％，显著高于对照组，经Χ^2检验，P〈0．01。结论氨碘肽滴眼液、地塞米松注射液、维生素C注射液离子导入的方法治疗玻璃体积血疗效确切，避免了口服、局部给药带来的副作用。

Objective To study the efficacy of amiotide, dexamethasone and vitamin C to treat vitreous hemorrhage. Methods Subjects were 81 patients （81 eyes） with vitreous hemorrhage presented to our hospital between August 2011 and January 2013. Patients were randomly assigned to receive standard management （40 patients, control group） or routine treatment plus iontophoresis with a combination of amiotide, dexamethasone and vitamin C （41 patients, treatment group ）. Results The effective rate after 2 -3 courses of treatment was 90.2% in treatment group, and was significantly higher than in control group （ chi-square test, P 〈0. 01 ）. Conclusion Iontophoresis with the combination of amiotide, dexamethasone and vitamin C is an effective treatment for vitreous hemorrhage.